Regulation of elastin gene transcription by interleukin-1 beta-induced C/EBP beta isoforms.
We previously showed that interleukin (IL)-1beta decreases elastin gene transcription through activation of the NF-kappaB subunit p65 in neonatal rat lung fibroblasts. The present study was undertaken to further explore the molecular mechanisms responsible for the inhibitory effect of IL-1beta on elastin gene transcription. We found that cycloheximide blocked IL-1beta-induced downregulation of elastin mRNA but did not inhibit IL-1beta-induced translocation of p65 into the nucleus. IL-1beta treatment increased CCAAT/enhancer-binding protein (C/EBP)beta mRNA and protein levels including liver-enriched activating protein (LAP) and liver-enriched inhibitory protein (LIP), which was cycloheximide sensitive. C/EBPbeta isoforms bound a GCAAT-containing sequence in the proximal elastin promoter as determined by electrophoretic gel shift studies and confirmed by using specific anti-C/EBPbeta antibodies and by competition studies with oligonucleotides. Transient transfection of LIP expression vectors strongly decreased the transcriptional activity of the cotransfected elastin promoter and decreased levels of endogenous elastin mRNA. We demonstrated that IL-1beta-induced downregulation of elastin mRNA is dependent on NF-kappaB activation and C/EBPbeta expression. These results indicate that IL-1beta treatment activates NF-kappaB, which subsequently induces LIP expression and inhibition of elastin gene transcription.
Kuang
Ping-Ping
PP
Pulmonary Center, R 304, Boston Univ. School of Medicine, 80 E. Concord St., Boston, MA 02118, USA. pkuang@lung.bumc.bu.edu
Goldstein
Ronald H
RH
D000818:Animals; D000831:Animals, Newborn; D015152:Blotting, Northern; D015153:Blotting, Western; D022782:CCAAT-Enhancer-Binding Protein-beta / Q000187:drug effects / Q000378:metabolism*; D015536:Down-Regulation; D004549:Elastin / Q000187:drug effects / Q000235:genetics*; D005347:Fibroblasts / Q000502:physiology; D005786:Gene Expression Regulation; D007375:Interleukin-1 / Q000494:pharmacology*; D008168:Lung / Q000166:cytology; D016328:NF-kappa B / Q000187:drug effects / Q000378:metabolism*; D011233:Precipitin Tests; D011401:Promoter Regions, Genetic; D020033:Protein Isoforms / Q000187:drug effects / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D014158:Transcription, Genetic / Q000187:drug effects
D022782:CCAAT-Enhancer-Binding Protein-beta; D007375:Interleukin-1; D016328:NF-kappa B; D020033:Protein Isoforms; D012333:RNA, Messenger; D004549:Elastin